PFIZER
|
The Current P/S Ratio of PFIZER is 6.69.
| Share Price | ₹3,760.4 | Oct 29,2026 |
| Market Cap | ₹17,185.0 Cr | |
| Sales-TTM | ₹2,569.8 Cr | TTM-Standalone Results |
| Price/Sales | 6.69x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PFIZER
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹17,185.0 Cr] as on Oct 29,2026
(/) Sales [ ₹2,569.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 6.69x ]
Thus, for PFIZER , the investors are currently willing to pay '6.69 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PFIZER !
The chart below summarizes the trend in P/S Ratio of PFIZER over the last five years.
Historical PS (Price/Sales) ratio chart of PFIZER
PS Ratio Performance Analysis for PFIZER
- PFIZER 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 7.90x.
- PFIZER 's operated at median p/e ratio of 8.03x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/e ratio peaked in Mar2024 at 8.75x.
- PFIZER 's p/e ratio hit its five-year low in Mar2023 of 6.54x.
How does PFIZER 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PFIZER | 2,569.8 | 6.69 | 17,185.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.06 | 422,991.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.82 | 256,310.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 9.98 | 173,604.0 |
| CIPLA LTD | 28,138.9 | 3.90 | 109,628.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.38 | 111,722.0 |
| MANKIND PHARMA LTD | 15,378.6 | 6.61 | 101,659.0 |
| LUPIN LTD | 29,966.6 | 3.05 | 91,367.1 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.14 | 118,304.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.73 | 95,225.0 |
| LAURUS LABS LTD | 7,822.5 | 15.51 | 121,300.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PFIZER 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.73x |
| Max industry PS | 22.82x |
| Median industry PS | 6.61x |
| Average industry PS | 7.80x |
You may also like the below Video Courses